Georgia Zarkada

2.8k total citations
17 papers, 1.4k citations indexed

About

Georgia Zarkada is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Georgia Zarkada has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 4 papers in Physiology. Recurrent topics in Georgia Zarkada's work include Angiogenesis and VEGF in Cancer (12 papers), Lymphatic System and Diseases (10 papers) and Sympathectomy and Hyperhidrosis Treatments (3 papers). Georgia Zarkada is often cited by papers focused on Angiogenesis and VEGF in Cancer (12 papers), Lymphatic System and Diseases (10 papers) and Sympathectomy and Hyperhidrosis Treatments (3 papers). Georgia Zarkada collaborates with scholars based in Finland, United States and France. Georgia Zarkada's co-authors include Kari Alitalo, Harri Nurmi, Anne Eichmann, Krista Heinolainen, Taija Mäkinen, Tuomas Tammela, Pipsa Saharinen, Wei Zheng, Marius R. Robciuc and Feng Zhang and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Georgia Zarkada

17 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georgia Zarkada Finland 14 739 620 255 218 201 17 1.4k
Marja Lohela Finland 11 902 1.2× 774 1.2× 195 0.8× 111 0.5× 237 1.2× 16 1.6k
Alexandre Dubrac France 19 863 1.2× 247 0.4× 140 0.5× 257 1.2× 206 1.0× 35 1.5k
Denis Tvorogov Finland 20 847 1.1× 682 1.1× 160 0.6× 162 0.7× 200 1.0× 29 1.4k
Leorah Ross United States 7 931 1.3× 253 0.4× 285 1.1× 148 0.7× 166 0.8× 23 1.6k
Xiaowu Gu United States 16 493 0.7× 363 0.6× 95 0.4× 214 1.0× 128 0.6× 24 1.1k
Dianne Mitchell United States 17 814 1.1× 192 0.3× 162 0.6× 111 0.5× 158 0.8× 28 1.4k
Lori C. Gowen United States 12 1.2k 1.6× 440 0.7× 113 0.4× 136 0.6× 159 0.8× 13 1.8k
Claudia Prahst United States 16 1.1k 1.5× 338 0.5× 71 0.3× 264 1.2× 148 0.7× 17 1.6k
Gakuji Hashimoto Japan 11 929 1.3× 224 0.4× 243 1.0× 134 0.6× 198 1.0× 18 1.6k
Anil K. Kamaraju United States 9 750 1.0× 318 0.5× 312 1.2× 199 0.9× 152 0.8× 10 1.4k

Countries citing papers authored by Georgia Zarkada

Since Specialization
Citations

This map shows the geographic impact of Georgia Zarkada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgia Zarkada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgia Zarkada more than expected).

Fields of papers citing papers by Georgia Zarkada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgia Zarkada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgia Zarkada. The network helps show where Georgia Zarkada may publish in the future.

Co-authorship network of co-authors of Georgia Zarkada

This figure shows the co-authorship network connecting the top 25 collaborators of Georgia Zarkada. A scholar is included among the top collaborators of Georgia Zarkada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgia Zarkada. Georgia Zarkada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Park, Saejeong, Zhiyuan Ma, Georgia Zarkada, et al.. (2022). Endothelial β‐arrestins regulate mechanotransduction by the type II bone morphogenetic protein receptor in primary cilia. Pulmonary Circulation. 12(4). e12167–e12167. 4 indexed citations
2.
Min, Elizabeth, Nicolas Baeyens, Brian G. Coon, et al.. (2021). Activation of Smad2/3 signaling by low fluid shear stress mediates artery inward remodeling. Proceedings of the National Academy of Sciences. 118(37). 48 indexed citations
3.
Li, Jinyu, Luiz Henrique Geraldo, Alexandre Dubrac, Georgia Zarkada, & Anne Eichmann. (2021). Slit2-Robo Signaling Promotes Glomerular Vascularization and Nephron Development. Journal of the American Society of Nephrology. 32(9). 2255–2272. 8 indexed citations
4.
Zarkada, Georgia, Joel P. Howard, Hyojin Park, et al.. (2021). Specialized endothelial tip cells guide neuroretina vascularization and blood-retina-barrier formation. Developmental Cell. 56(15). 2237–2251.e6. 61 indexed citations
5.
Zhang, Feng, et al.. (2020). Lymphatic Endothelial Cell Junctions: Molecular Regulation in Physiology and Diseases. Frontiers in Physiology. 11. 509–509. 70 indexed citations
6.
Zhang, Feng, Georgia Zarkada, Jinah Han, et al.. (2018). Lacteal junction zippering protects against diet-induced obesity. Science. 361(6402). 599–603. 166 indexed citations
7.
Heinolainen, Krista, Sinem Karaman, Gabriela D’Amico, et al.. (2017). VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling. Circulation Research. 120(9). 1414–1425. 126 indexed citations
8.
Raissadati, Alireza, S. Syrjälä, Georgia Zarkada, et al.. (2015). Ischemia–Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts. American Journal of Transplantation. 16(4). 1160–1172. 37 indexed citations
9.
Zarkada, Georgia, Krista Heinolainen, Taija Mäkinen, Yoshiaki Kubota, & Kari Alitalo. (2015). VEGFR3 does not sustain retinal angiogenesis without VEGFR2. Proceedings of the National Academy of Sciences. 112(3). 761–766. 97 indexed citations
10.
Nurmi, Harri, Pipsa Saharinen, Georgia Zarkada, et al.. (2015). VEGF ‐C is required for intestinal lymphatic vessel maintenance and lipid absorption. EMBO Molecular Medicine. 7(11). 1418–1425. 162 indexed citations
11.
D’Amico, Gabriela, Emilia A. Korhonen, Andrey Anisimov, et al.. (2014). Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy. Journal of Clinical Investigation. 124(2). 824–834. 65 indexed citations
12.
Aspelund, Aleksanteri, Tuomas Tammela, Salli Antila, et al.. (2014). The Schlemm’s canal is a VEGF-C/VEGFR-3–responsive lymphatic-like vessel. Journal of Clinical Investigation. 124(9). 3975–3986. 171 indexed citations
13.
Anisimov, Andrey, Veli‐Matti Leppänen, Denis Tvorogov, et al.. (2013). The Basis for the Distinct Biological Activities of Vascular Endothelial Growth Factor Receptor–1 Ligands. Science Signaling. 6(282). ra52–ra52. 46 indexed citations
14.
Villefranc, Jacques A., Stefania Nicoli, Katie Bentley, et al.. (2013). A truncation allele in vascular endothelial growth factor c reveals distinct modes of signaling during lymphatic and vascular development. Development. 140(7). 1497–1506. 88 indexed citations
15.
Gaál, Emília Ilona, Tuomas Tammela, Andrey Anisimov, et al.. (2013). Comparison of vascular growth factors in the murine brain reveals placenta growth factor as prime candidate for CNS revascularization. Blood. 122(5). 658–665. 27 indexed citations
16.
Holopainen, Tanja, Pipsa Saharinen, Gabriela D’Amico, et al.. (2012). Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis. JNCI Journal of the National Cancer Institute. 104(6). 461–475. 6 indexed citations
17.
Tammela, Tuomas, Georgia Zarkada, Harri Nurmi, et al.. (2011). VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nature Cell Biology. 13(10). 1202–1213. 237 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marja Lohela Breakdown of academic impact, for papers by Alexandre Dubrac Breakdown of academic impact, for papers by Denis Tvorogov Breakdown of academic impact, for papers by Leorah Ross Breakdown of academic impact, for papers by Xiaowu Gu Breakdown of academic impact, for papers by Dianne Mitchell Breakdown of academic impact, for papers by Lori C. Gowen Breakdown of academic impact, for papers by Claudia Prahst Breakdown of academic impact, for papers by Gakuji Hashimoto Breakdown of academic impact, for papers by Anil K. Kamaraju
Rankless by CCL
2026